The bar chart illustrates the percentage distribution of drug sales made by the company in Asia, Europe and Africa, North America and South America between 2002 and 2006.
Overall, Europe ans Africa recorded the highest share throughout the period; whereas South America represented the lowest percentage. Asia’s share increased steadily over the five-year timeframe.
Looking at the upward share, Europe and Africa, which was the dominant market, started at 44% in 2002, peaked at 48% in 2004, and conluded at 40% in 2006. Regarding the sales in Asia, it experienced a slightly increase throughout the period. It stood at 12% at the beginning of period, reached at 22% in 2004, and peaked at 28% in 2006.
North America declined stedily during the given timeframe, starting with 33% it dropped to 21% in 2005 and remained the same at the end of the period. South America made up 11% in 2002, dropped to 6% in 2004, and recovered the initial share 11% in 2006.
